These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38954321)

  • 1. Assessing Substance Use Disorder Symptoms with a Checklist among Primary Care Patients with Opioid Use Disorder and/or Long-Term Opioid Treatment: An Observational Study.
    Williams EC; Matson TE; Hallgren KA; Oliver M; Wang X; Bradley KA
    J Gen Intern Med; 2024 Sep; 39(12):2169-2178. PubMed ID: 38954321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric Performance of a Substance Use Symptom Checklist to Help Clinicians Assess Substance Use Disorder in Primary Care.
    Matson TE; Hallgren KA; Lapham GT; Oliver M; Wang X; Williams EC; Bradley KA
    JAMA Netw Open; 2023 May; 6(5):e2316283. PubMed ID: 37234003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical Assessment of Alcohol Use Disorder in Routine Primary Care: Performance of an Alcohol Symptom Checklist.
    Hallgren KA; Matson TE; Oliver M; Witkiewitz K; Bobb JF; Lee AK; Caldeiro RM; Kivlahan D; Bradley KA
    J Gen Intern Med; 2022 Jun; 37(8):1885-1893. PubMed ID: 34398395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems.
    Bagley SM; Chavez L; Braciszewski JM; Akolsile M; Boudreau DM; Lapham G; Campbell CI; Bart G; Yarborough BJH; Samet JH; Saxon AJ; Rossom RC; Binswanger IA; Murphy MT; Glass JE; Bradley KA;
    Addict Sci Clin Pract; 2021 Jul; 16(1):46. PubMed ID: 34233750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of treatment by Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
    O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB
    Drug Alcohol Depend; 2020 Dec; 217():108261. PubMed ID: 32979735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings.
    Frost MC; Soyer EM; Achtmeyer CE; Hawkins EJ; Glass JE; Hallgren KA; Williams EC
    Addict Sci Clin Pract; 2023 May; 18(1):26. PubMed ID: 37143162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
    Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
    Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equivalence of Alcohol Use Disorder Symptom Assessments in Routine Clinical Care When Completed Remotely via Online Patient Portals Versus In Clinic via Paper Questionnaires: Psychometric Evaluation.
    Matson TE; Lee AK; Oliver M; Bradley KA; Hallgren KA
    J Med Internet Res; 2024 Jul; 26():e52101. PubMed ID: 39038284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV Prevalence and HIV Screening History Among a Veterans Association Cohort of People with Opioid and Alcohol Use Disorders.
    McCann NC; Davenport MJ; Mandavia AD; Stein MD; Livingston NA
    J Gen Intern Med; 2024 Feb; 39(3):403-410. PubMed ID: 37848765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with clinician treatment recommendations for patients with a new diagnosis of opioid use disorder.
    Lin LA; Powell VD; Macleod C; Bohnert ASB; Lagisetty P
    J Subst Abuse Treat; 2022 Oct; 141():108827. PubMed ID: 35863212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of polysubstance use disorder with treatment quality among Medicaid beneficiaries with opioid use disorder.
    Smart R; Kim JY; Kennedy S; Tang L; Allen L; Crane D; Mack A; Mohamoud S; Pauly N; Perez R; Donohue J
    J Subst Abuse Treat; 2023 Jan; 144():108921. PubMed ID: 36327615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance Use Disorder Treatment Following Clinician-Initiated Discontinuation of Long-Term Opioid Therapy Resulting from an Aberrant Urine Drug Test.
    Nugent SM; Dobscha SK; Morasco BJ; Demidenko MI; Meath THA; Frank JW; Lovejoy TI
    J Gen Intern Med; 2017 Oct; 32(10):1076-1082. PubMed ID: 28600754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems.
    Boudreau DM; Lapham G; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Campbell CI; Rossom RC; Binswanger IA; Yarborough BJ; Arnsten JH; Cunningham CO; Glass JE; Murphy MT; Zare M; Hechter RC; Ahmedani B; Braciszewski JM; Horigian VE; Szapocznik J; Samet JH; Saxon AJ; Schwartz RP; Bradley KA
    J Subst Abuse Treat; 2020 Mar; 112S():41-48. PubMed ID: 32220410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder.
    Tabatabaeepour N; Morgan JR; Jalali A; Kapadia SN; Meinhofer A
    J Subst Abuse Treat; 2022 Sep; 140():108800. PubMed ID: 35577664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use.
    Xu KY; Mintz CM; Presnall N; Bierut LJ; Grucza RA
    JAMA Netw Open; 2022 May; 5(5):e2211363. PubMed ID: 35536575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Test-retest reliability of DSM-5 substance use symptom checklists used in primary care and mental health care settings.
    Hallgren KA; Matson TE; Oliver M; Wang X; Williams EC; Bradley KA
    Drug Alcohol Depend; 2024 Mar; 256():111108. PubMed ID: 38295510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construct and differential item functioning in the assessment of prescription opioid use disorders among American adolescents.
    Wu LT; Ringwalt CL; Yang C; Reeve BB; Pan JJ; Blazer DG
    J Am Acad Child Adolesc Psychiatry; 2009 May; 48(5):563-572. PubMed ID: 19318987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine Assessment of Symptoms of Substance Use Disorders in Primary Care: Prevalence and Severity of Reported Symptoms.
    Sayre M; Lapham GT; Lee AK; Oliver M; Bobb JF; Caldeiro RM; Bradley KA
    J Gen Intern Med; 2020 Apr; 35(4):1111-1119. PubMed ID: 31974903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Substance Use Disorders on the Association Between Guideline-concordant Long-term Opioid Therapy and All-cause Mortality.
    Gaither JR; Goulet JL; Becker WC; Crystal S; Edelman EJ; Gordon K; Kerns RD; Rimland D; Skanderson M; Justice AC; Fiellin DA
    J Addict Med; 2016; 10(6):418-428. PubMed ID: 27610580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.